|
1
|
Neuhaus H: Intrahepatic stones: the
percutaneous approach. Can J Gastroenterol. 13:467–472.
1999.PubMed/NCBI
|
|
2
|
Mori T, Sugiyama M and Atomi Y: Gallstone
disease: Management of intrahepatic stones. Best Prac Res Clin
Gastroenterol. 20:1117–1137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaufman HS, Magnuson TH, Lillemoe KD,
Frasca P and Pitt HA: The role of bacteria in gallbladder and
common duct stone formation. Ann Surg. 209:584–592. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cetta FM: Bile infection documented as
initial event in the pathogenesis of brown pigment biliary stones.
Hepatology. 6:482–489. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakayama F and Koga A: Hepatolithiasis:
present status. World J Surg. 8:9–14. 1984. View Article : Google Scholar
|
|
6
|
Chang TM and Passaro E Jr: Intrahepatic
stones: the Taiwan experience. Am J Surg. 146:241–244. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakayama F, Soloway RD, Nakama T, et al:
Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci.
31:21–26. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oude Elferink RP and Paulusma CC: Function
and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
Pflugers Arch. 453:601–610. 2007.PubMed/NCBI
|
|
9
|
Arrese M and Ananthanarayanan M: The bile
salt export pump: molecular properties, function and regulation.
Pflugers Arch. 449:123–131. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meier Y, Pauli-Magnus C, Zanger UM, et al:
Interindividual variability of canalicular ATP-binding-cassette
(ABC)-transporter expression in human liver. Hepatology. 44:62–74.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jacquemin E: Role of multidrug resistance
3 deficiency in pediatric and adult liver disease: one gene for
three diseases. Semin Liver Dis. 21:551–562. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jacquemin E, Cresteil D, Manouvrier S,
Boute O and Hadchouel M: Heterozygous non-sense mutation of the
MDR3 gene in familial intrahepatic cholestasis of pregnancy.
Lancet. 353:210–211. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dixon PH, Weerasekera N, Linton KJ, et al:
Heterozygous MDR3 missense mutation associated with intrahepatic
cholestasis of pregnancy: evidence for a defect in protein
trafficking. Hum Mol Genet. 9:1209–1217. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lucena JF, Herrero JI, Quiroga J, et al: A
multidrug resistance 3 gene mutation causing cholelithiasis,
cholestasis of pregnancy, and adulthood biliary cirrhosis.
Gastroenterology. 124:1037–1042. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gendrot C, Bacq Y, Brechot MC, Lansac J
and Andres C: A second heterozygous MDR3 nonsense mutation
associated with intrahepatic cholestasis of pregnancy. J Med Genet.
40:e322003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Müllenbach R, Linton KJ, Wiltshire S, et
al: ABCB4 gene sequence variation in women with intrahepatic
cholestasis of pregnancy. J Med Genet. 40:e702003.PubMed/NCBI
|
|
17
|
Pauli-Magnus C, Lang T, Meier Y, et al:
Sequence analysis of bile salt export pump (ABCB11) and multidrug
resistance P-glycoprotein 3 (ABCB4, MDR3) in patients with
intrahepatic cholestasis of pregnancy. Pharmacogenetics. 14:91–102.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Floreani A, Carderi I, Paternoster D, et
al: Hepatobiliary phospholipid transporter ABCB4, MDR3 gene
variants in a large cohort of Italian women with intrahepatic
cholestasis of pregnancy. Dig Liver Dis. 40:366–370. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schneider G, Paus TC, Kullak-Ublick GA, et
al: Linkage between a new splicing site mutation in the MDR3 alias
ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology.
45:150–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poupon R, Barbu V, Chamouard P, Wendum D,
Rosmorduc O and Housset C: Combined features of low
phospholipid-associated cholelithiasis and progressive familial
intrahepatic cholestasis 3. Liver Int. 30:327–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakken KE, Labori KJ, Rødningen OK, et al:
ABCB4 sequence variations in young adults with cholesterol
gallstone disease. Liver Int. 29:743–747. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Noé J, Stieger B and Meier PJ: Functional
expression of the canalicular bile salt export pump of human liver.
Gastroenterology. 123:1659–1666. 2002.PubMed/NCBI
|
|
23
|
Byrne JA, Strautnieks SS, Mieli-Vergani G,
Higgins CF, Linton KJ and Thompson RJ: The human bile salt export
pump: characterization of substrate specificity and identification
of inhibitors. Gastroenterology. 123:1649–1658. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lam P, Pearson CL, Soroka CJ, Xu S,
Mennone A and Boyer JL: Levels of plasma membrane expression in
progressive and benign mutations of the bile salt export pump
(Bsep/Abcb11) correlate with severity of cholestatic diseases. Am J
Physiol Cell Physiol. 293:C1709–C1716. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van Mil SW, van der Woerd WL, van der
Brugge G, et al: Benign recurrent intrahepatic cholestasis type 2
is caused by mutations in ABCB11. Gastroenterology. 127:379–384.
2004.PubMed/NCBI
|
|
26
|
Strautnieks SS, Bull LN, Knisely AS, et
al: A gene encoding a liver-specific ABC transporter is mutated in
progressive familial intrahepatic cholestasis. Nat Genet.
20:233–238. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dixon PH, van Mil SW, Chambers J, et al:
Contribution of variant alleles of ABCB11 to susceptibility to
intrahepatic cholestasis of pregnancy. Gut. 58:537–544. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Acalovschi M, Tirziu S, Chiorean E,
Krawczyk M, Grünhage F and Lammert F: Common variants of ABCB4 and
ABCB11 and plasma lipid levels: a study in sib pairs with
gallstones, and controls. Lipids. 44:521–526. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marschall HU, Katsika D, Rudling M and
Einarsson C: The genetic background of gallstone formation: an
update. Biochem Biophys Res Commun. 396:58–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shoda J, Inada Y and Osuga T: Molecular
pathogenesis of hepatolithiasis - a type of low
phospholipid-associated cholelithiasis. Front Biosci. 11:669–675.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tazuma S: Gallstone disease: Epidemiology,
pathogenesis, and classification of biliary stones (common bile
duct and intrahepatic). Best Pract Res Clin Gastroenterol.
20:1075–1083. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen HL, Liu YJ, Su YN, et al: Diagnosis
of BSEP/ABCB11 mutations in Asian patients with cholestasis using
denaturing high performance liquid chromatography. J Pediatr.
153:825–832. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu LY, Wang XH, Lu Y, Zhu QR and Wang JS:
Association of variants of ABCB11 with transient neonatal
cholestasis. Pediatr Int. 55:138–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Byrne JA, Strautnieks SS, Ihrke G, et al:
Missense mutations and single nucleotide polymorphisms in ABCB11
impair bile salt export pump processing and function or disrupt
pre-messenger RNA splicing. Hepatology. 49:553–567. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Keitel V, Vogt C, Häussinger D and Kubitz
R: Combined mutations of canalicular transporter proteins cause
severe intrahepatic cholestasis of pregnancy. Gastroenterology.
131:624–629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pauli-Magnus C, Kerb R, Fattinger K, et
al: BSEP and MDR3 haplotype structure in healthy Caucasians,
primary biliary cirrhosis and primary sclerosing cholangitis.
Hepatology. 39:779–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ho RH, Leake BF, Kilkenny DM, et al:
Polymorphic variants in the human bile salt export pump (BSEP;
ABCB11): functional characterization and interindividual
variability. Pharmacogenet Genomics. 20:45–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fattinger K, Funk C, Pantze M, et al: The
endothelin antagonist bosentan inhibits the canalicular bile salt
export pump: a potential mechanism for hepatic adverse reactions.
Clin Pharmacol Ther. 69:223–231. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eloranta ML, Häkli T, Hiltunen M,
Helisalmi S, Punnonen K and Heinonen S: Association of single
nucleotide polymorphisms of the bile salt export pump gene with
intrahepatic cholestasis of pregnancy. Scand J Gastroenterol.
38:648–652. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lang C, Meier Y, Stieger B, et al:
Mutations and polymorphisms in the bile salt export pump and the
multidrug resistance protein 3 associated with drug-induced liver
injury. Pharmacogenet Genomics. 17:47–60. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Muehlenberg K, Wiedmann K, Keppeler H,
Sauerbruch T and Lammert F: Recurrent intrahepatic cholestasis of
pregnancy and chain-like choledocholithiasis in a female patient
with stop codon in the ABDC4-gene of the hepatobiliary phospholipid
transporter. Z Gastroenterol. 46:48–53. 2008.(In German).
|
|
42
|
Kubitz R, Keitel V, Scheuring S, Köhrer K
and Häussinger D: Benign recurrent intrahepatic cholestasis
associated with mutations of the bile salt export pump. J Clin
Gastroenterol. 40:171–175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Higuchi H and Gores GJ: Bile acid
regulation of hepatic physiology: IV. Bile acids and death
receptors. Am J Physiol Gastrointest Liver Physiol. 284:G734–G738.
2003.PubMed/NCBI
|
